Fellowship · Washington, DC
Sponsored by MedStar Health Georgetown University · Director Amol Rangnekar
Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021.
Clinical and molecular hepatology · 2025 · 68 citations · Hanna Blaney
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease.
Hepatology communications · 2024 · 134 citations · Veronica Nguyen
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021 · 193 citations · Brett Sadowski, Veronica Nguyen
Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes.
Scientific reports · 2025 · 30 citations · Rachel Redfield
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.
Hepatology (Baltimore, Md.) · 2021 · 136 citations · Ryan Kwok
Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users.
Journal of xenobiotics · 2023 · 34 citations · Brett Sadowski
Management of alcohol withdrawal syndrome in patients with alcohol-associated liver disease.
Hepatology communications · 2024 · 19 citations · Hanna Blaney
Malnutrition Increases Hospital Length of Stay and Mortality among Adult Inpatients with COVID-19.
Nutrients · 2022 · 40 citations · Ahyoung Kim